Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title | Funding Agency | Discipline | Who's Eligible | Award Amount |
Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 9/05/2022 | Notice of Special Interest: SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/20/2022 |
| Deadline: 9/01/2022 | NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/13/2022 |
| Deadline: 8/25/2022 | Developmental AIDS Research Centers on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,000,000 | 5/13/2022 |
| Deadline: 8/25/2022 | NIMH AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $7,500,000 | 5/13/2022 |
| Deadline: 6/05/2022 | Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,875,000 | 5/09/2022 |
| Deadline: 8/10/2022 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/09/2022 |
| Deadline: 7/15/2022 | Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/06/2022 |
| Deadline: 8/15/2022 | NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,500,000 | 5/03/2022 |
| Deadline: 9/05/2022 | Notice of Special Interest (NOSI): Towards Developing a Cure for HBV in HIV/HBV Co-Infection | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/02/2022 |
| Deadline: 6/14/2022 | Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/02/2022 |
| Deadline: 9/13/2022 | NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/29/2022 |
| Deadline: 7/22/2022 | NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $5,000,000 | 4/26/2022 |
| Deadline: 6/09/2022 | HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $7,500,000 | 4/25/2022 |
| Deadline: 9/30/2022 | Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/22/2022 |
| Deadline: 9/30/2022 | Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/22/2022 |
| Deadline: 10/21/2022 | Notice of Intent to Publish a Funding Opportunity Announcement for Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/22/2022 |
| Graduate Medical Education (GME): Neuro-Oncology | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 | |
| Deadline: 9/27/2018 | Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 10/09/2018 | Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $5,000,000 | 4/18/2022 |
| National Center for Advancing Translational Sciences (NCATS) -- Collaborative Proposals | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
